6260
D. Didier et al. / Tetrahedron 64 (2008) 6252–6262
a crude product, which was purified by column chromatography on
SiO2 (details are specified below for individual compounds). In
some cases reaction conditions were varied as specified in Tables 1–
3, but the work up and purification procedures were always the
same for a given compound.
For the following Tro¨ger’s base analogues spectral data were
identical with those published before: (ꢀ)-1a,24 (ꢀ)-1b,32 (ꢀ)-1j,24
(ꢀ)-1k,6 (ꢀ)-1l–o,27 (ꢀ)-1p,4 (ꢀ)-1q,25 (ꢀ)-2a,d,24 (ꢀ)-2e,9 and
(ꢀ)-3b.35 The following compounds have been reported before, but
without spectral characterization: (ꢀ)-1g,h,25 and (ꢀ)-2g.34 We
therefore give below their 1H and 13C spectra. For all other Tro¨ger’s
base analogues we report full analytical details below.
29.1, 31.4, 31.7, 35.4, 58.6, 66.9,124.8,126.5,127.3, 127.5, 138.6,145.7.
HREIMS: m/z: calcd for
390.3025.
C
27H38N2 ([M]þ) 390.3035; found:
4.2.5. (ꢀ)-2,8-Dimethoxy-6H,12H-5,11-methanodibenzo[b,f][1,5]-
diazocine ((ꢀ)-1g)
Prepared according to the general procedure from 4-methoxy-
aniline 4g (615 mg, 5.00 mmol). The crude product was purified by
column chromatography (CH2Cl2/AcOEt 4:1) to afford pure (ꢀ)-1g
(469 mg, 66%) as a white solid; mp 171–173 ꢂC (lit.26 mp 172–
173 ꢂC). 1H NMR (300 MHz, CDCl3, 25 ꢂC):
d
¼3.70 (s, 6H), 4.08 (d,
2JH,H¼17.8 Hz, 2H), 4.29 (s, 2H), 4.65 (d, 2JH,H¼17.8 Hz, 2H), 6.42 (d,
4JH,H¼3.0 Hz, 2H), 6.74 (dd, 3JH,H¼8.7 Hz, 4JH,H¼3.0 Hz, 2H), 7.06 (d,
13
4.2.1. (ꢀ)-2,8-Diethyl-6H,12H-5,11-methanodibenzo[b,f][1,5]-
diazocine ((ꢀ)-1c)
3JH,H¼8.7 Hz, 2H). C NMR (75 MHz, CDCl3, 25 ꢂC):
d¼55.3, 58.9,
67.2, 110.9, 114.0, 125.9, 128.6, 140.9, 156.1.
Prepared according to the general procedure from 4-ethylani-
line 4c (605 mg, 5.00 mmol). The crude product was purified by
column chromatography (CH2Cl2/AcOEt 5:1) to afford pure (ꢀ)-1c
(597 mg, 86%) as a colorless oil, which partially solidified upon
standing for a few weeks, but did not produce a material with
4.2.6. (ꢀ)-2,8-Bis(methylsulfanyl)-6H,12H-5,11-methanodibenzo-
[b,f][1,5]diazocine ((ꢀ)-1h)
Prepared according to the general procedure from amine 4h
(695 mg, 5.00 mmol). The crude product was purified by column
chromatography (CH2Cl2/AcOEt 4:1, then 1:1) to afford pure (ꢀ)-1h
(527 mg, 69%) as an off-white solid; mp 186–187 ꢂC (lit.26 mp 184–
a
distinct mp. 1H NMR (300 MHz, CDCl3, 25 ꢂC):
d
¼1.15 (t,
3
2
3JH,H¼7.7 Hz, 6H), 2.51 (q, JH,H¼7.7 Hz, 4H), 4.13 (d, JH,H¼16.7 Hz,
2
4
2H), 4.29 (s, 2H), 4.66 (d, JH,H¼16.7 Hz, 2H), 6.72 (d, JH,H¼1.8 Hz,
185 ꢂC). 1H NMR (300 MHz, CDCl3, 25 ꢂC):
d
¼2.40 (s, 6H), 4.10 (d,
3
4
3
2H), 6.98 (dd, JH,H¼8.1 Hz, JH,H¼1.8 Hz, 2H), 7.05 (d, JH,H¼8.1 Hz,
2JH,H¼16.9 Hz, 2H), 4.28 (s, 2H), 4.64 (d, 2JH,H¼16.9 Hz, 2H), 6.82 (d,
2H). 13C NMR (75 MHz, CDCl3, 25 ꢂC):
d
¼15.4, 28.2, 58.6, 66.9, 124.9,
4JH,H¼2.2 Hz, 2H), 7.05 (d, 3JH,H¼8.4 Hz, 2H), 7.10 (dd, JH,H¼8.4 Hz,
3
13
126.0, 126.8, 127.6, 139.7, 145.7. HREIMS: m/z: calcd for C19H22N2
4JH,H¼2.2 Hz, 2H). C NMR (75 MHz, CDCl3, 25 ꢂC):
d¼16.6, 58.6,
([M]þ) 278.1783; found: 278.1788.
66.9, 125.5, 125.7, 126.8, 128.4, 133.1, 145.6. HREIMS: m/z: calcd for
C
17H18N2S2 ([M]þ) 314.0911; found: 314.0908.
4.2.2. (ꢀ)-2,8-Di(iso-propyl)-6H,12H-5,11-methanodibenzo[b,f]-
[1,5]diazocine ((ꢀ)-1d)
4.2.7. (ꢀ)-[(6H,12H-5,11-Methanodibenzo[b,f][1,5]diazocin-2,8-
diyl)bis(4,1-phenylene)]dicarbonitrile ((ꢀ)-1r)
Prepared according to the general procedure from 4-(iso-pro-
pyl)aniline 4d (675 mg, 5.00 mmol). The crude product was puri-
fied by column chromatography (CH2Cl2/AcOEt 5:1) to afford pure
Prepared according to the general procedure from amine 4r
(487 mg, 2.50 mmol), paraformaldehyde (150 mg, 5.00 mmol), and
CF3COOH (5 mL). The crude product was purified by column
chromatography (CH2Cl2/AcOEt 9:1) to afford pure (ꢀ)-1r (0.231 g,
(ꢀ)-1d (655 mg, 86%) as a white solid; mp 109–110.5 ꢂC. 1H NMR
3
(300 MHz, CDCl3, 25 ꢂC):
d
2
¼1.16 (d, JH,H¼6.9 Hz, 12H), 2.78 (sept,
3JH,H¼6.9 Hz, 2H), 4.14 (d, JH,H¼16.7 Hz, 2H), 4.29 (s, 2H), 4.68 (d,
43%) as a white solid; mp 109–110.5 ꢂC. 1H NMR (300 MHz, CDCl3,
2JH,H¼16.7 Hz, 2H), 6.74 (d, 4JH,H¼1.8 Hz, 2H), 7.02 (dd, 3JH,H¼8.4 Hz,
25 ꢂC):
d
¼4.30 (d, JH,H¼16.8 Hz, 2H), 4.38 (s, 2H), 4.81 (d,
2
4JH,H¼1.8 Hz, 2H), 7.07 (d, JH,H¼8.4 Hz, 2H). 13C NMR (75 MHz,
2JH,H¼16.8 Hz, 2H), 7.17 (d, JH,H¼2.1 Hz, 2H), 7.26 (d, JH,H¼8.4 Hz,
3
4
3
4
3
CDCl3, 25 ꢂC):
d
¼23.9, 33.5, 58.5, 66.8, 124.5, 124.9, 125.4, 127.5,
2H), 7.42 (dd, 3JH,H¼8.4 Hz, JH,H¼2.1 Hz, 2H), 7.57 (d, JH,H¼8.7 Hz,
144.3, 145.8. HREIMS: m/z: calcd for C21H26N2 ([M]þ) 306.2096;
4H), 7.66 (d, JH,H¼8.7 Hz, 4H). C NMR (75 MHz, CDCl3, 25 ꢂC):
3
13
found: 306.2091.
d
¼58.8, 66.9, 110.6, 118.9, 125.8, 125.8, 126.4, 127.3, 128.4, 132.6,
135.0, 145.0, 148.7; HRESIMS: m/z: calcd for C29H20N4Na ([MþNa]þ)
4.2.3. (ꢀ)-2,8-Di(tert-butyl)-6H,12H-5,11-methanodibenzo[b,f]-
[1,5]diazocine ((ꢀ)-1e)
447.1586; found: 447.1581.
Prepared according to the general procedure from 4-(tert-
butyl)aniline 4e (745 mg, 5.00 mmol). The crude product was pu-
rified by column chromatography (CH2Cl2/AcOEt 5:1) to afford pure
(ꢀ)-1e (733 mg, 88%) as a white solid; mp 207–209 ꢂC. 1H NMR
4.2.8. (ꢀ)-4,10-Dibromo-2,8-bis(trifluoromethyl)-6H,12H-5,11-
methanodibenzo[b,f][1,5]diazocine ((ꢀ)-2c)
Prepared according to the general procedure from amine 5c
(502 mg, 2.1 mmol), paraformaldehyde (130 mg, 4.30 mmol), and
CF3COOH (4 mL). The crude product was purified by column
chromatography (hexane/CH2Cl2 85:15) to afford pure (ꢀ)-2c
(300 MHz, CDCl3, 25 ꢂC):
d
¼1.24 (s, 18H), 4.15 (d, 2JH,H¼16.8 Hz, 2H),
2
4
4.28 (s, 2H), 4.69 (d, JH,H¼16.8 Hz, 2H), 6.90 (d, JH,H¼1.8 Hz, 2H),
3
3
4
7.07 (d, JH,H¼8.4 Hz, 2H), 7.18 (dd, JH,H¼8.4 Hz, JH,H¼1.8 Hz, 2H).
(0.181 g, 34%) as a white solid; mp 115–116 ꢂC. 1H NMR (300 MHz,
13C NMR (75 MHz, CDCl3, 25 ꢂC):
d
¼31.3, 34.2, 58.5, 66.8, 123.4,
CDCl3, 25 ꢂC):
d
¼4.37 (s, 2H), 4.43 (d, JH,H¼17.6 Hz, 2H), 4.67 (d,
2
4
4
124.3, 124.6, 127.1, 145.6, 146.6. HREIMS: m/z: calcd for C23H30N2
2JH,H¼17.6 Hz, 2H), 7.24 (d, JH,H¼1.1 Hz, 2H), 7.73 (d, JH,H¼1.1 Hz,
([M]þ) 334.2409; found: 334.2404.
2H). 13C NMR (75 MHz, CDCl3, 25 ꢂC):
d
¼55.2, 67.2, 120.4, 123.0 (q,
2
1JC,F¼272.4 Hz, CF3), 123.5 (q, JC,F¼3.6 Hz), 127.9 (q, JC,F¼33.1 Hz,
3
3
4.2.4. (ꢀ)-2,8-Dihexyl-6H,12H-5,11-methanodibenzo[b,f][1,5]-
diazocine ((ꢀ)-1f)
CCF3), 127.9 (q, JC,F¼3.6 Hz), 130.9, 147.8. HRESIMS: m/z: calcd for
79
C
H
Br2F6N2 ([MþH]þ) 514.9193; found: 514.9209.
17 11
Prepared according to the general procedure from 4-hexylani-
line 4f (885 mg, 5.00 mmol). The crude product was purified by
column chromatography (CH2Cl2/AcOEt 5:1) to afford pure (ꢀ)-1f
(770 mg, 79%) as a white solid; mp 61–63 ꢂC. 1H NMR (300 MHz,
4.2.9. (ꢀ)-2,4,8,10-Tetrabromo-6H,12H-5,11-methanodibenzo[b,f]-
[1,5]diazocine ((ꢀ)-2g)
Prepared according to the general procedure from amine 5g
(1.255 g, 5 mmol). The crude product was purified by column
chromatography (CH2Cl2) to afford pure (ꢀ)-2g (269 mg, 20%) to-
gether with 6,8-dibromo-3-(2,4-dibromophenyl)-1,2,3,4-tetrahy-
droquinazoline (7, 671 mg, 51%) and N-methyl-2,4-dibromoaniline
(8, 60 mg, 4.5%).
CDCl3, 25 ꢂC):
d
¼0.87 (t, 3JH,H¼6.7 Hz, 6H), 1.20–1.35 (m, 12H), 1.52
3
3
(quint, JH,H¼6.7 Hz, 4H), 2.46 (t, JH,H¼7.8 Hz, 4H), 4.12 (d,
2JH,H¼16.8 Hz, 2H), 4.29 (s, 2H), 4.66 (d, JH,H¼16.8 Hz, 2H), 6.70
2
(d, 4JH,H¼1.8 Hz, 2H), 6.96 (dd, 3JH,H¼8.2 Hz, 4JH,H¼1.8 Hz, 2H), 7.03
(d, 3JH,H¼8.2 Hz, 2H). 13C NMR (75 MHz, CDCl3, 25 ꢂC):
¼14.1, 22.6,
d